Routine director onboarding, no immediate trading signal. Monitor for future Form 4 filings by Dr. Kreher to gauge insider sentiment. The appointment itself does not indicate a material change in company outlook.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 6 $8.28entry
- T+1 · 4mo ago +1.09%α +0.21% · $8.37
- T+5 · 4mo ago +4.11%α +3.18% · $8.62
- T+20 · 4mo ago +1.69%α +2.11% · $8.42
- T+60 · 7w ago +18.72%α +15.15% · $9.83
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Dr. Nerissa Kreher has been appointed as a director of Xeris Biopharma Holdings, Inc., effective July 1, 2026, and filed a Form 3 initial statement of beneficial ownership. This is a routine administrative filing with no disclosure of actual holdings or material financial impact.
Key Facts
- Dr. Nerissa Kreher appointed as director, effective 2026-07-01
- Form 3 filed to report initial beneficial ownership (no ownership amounts disclosed)
- Power of Attorney granted to John Shannon, Beth Hecht, and Steve Pieper for Section 16 filings
Financial Impact
Not specified
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001867096-26-000051 |
| Document: 0001867096-26-000051-index-headers.html | 0001867096-26-000051 |
| Document: 0001867096-26-000051-index.html | 0001867096-26-000051 |
| Document: 0001867096-26-000051.txt | 0001867096-26-000051 |
Track record
25 reports on XERS
4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +45.52% at T+60 after the Aug 6, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $15.86 Now $16.70 +5.30% settles Dec 8
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $15.20 Now $16.70 +9.87% settles Dec 7
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 4, 202612d ago 3 Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $10.35 Now $16.70 +61.35% settles Dec 2
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $10.17 Now $16.70 +64.21% settles Dec 1
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $10.71 Now $16.70 +55.93% settles Nov 30
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $9.77 to $16.52 Now $16.70 +70.93% ▲ +69.09% +70.36% vs SPY
- Oct 2, 20266w ago Insider Cluster Neutral 3/10 Entry $10.13 to $10.71 Now $16.70 +64.86% ▲ +5.73% +8.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers